The Healthcare CRO Market is expected to be around US$ 67.40 Billion by 2028 at a CAGR of 7% in the given forecast period
A Contract Research Organisation, is nothing but Clinical Research Organization is a service organization that delivers support to the biotechnology and pharmaceutical industries in the form of outsourced pharmaceutical research services. Contract research outsourcing alliances offer cutting-edge services, and thus government organizations prefer assigning projects to contract research organizations, thereby facilitating the market development. Growing pressure on drug developers pertaining to clinical data management, stringent safety standards and regulatory environments is expected to drive the demand for contract research organizations within the healthcare sector. Moreover, the presence of an ever-expanding pharmaceutical industry has also generated ripples across the global healthcare contract research organization market. The importance of healthcare contract research organization can be evaluated from the level of outsourcing that has been done in the field of medical research. There is little contention about the advent of new services within the domain of healthcare contract research organization.
The global Healthcare CRO market is segregated on the basis of Service Type as Early Phase Development, Clinical Research Services, Laboratory Services, and Consulting Services. Based on Therapeutic Area the global Healthcare CRO market is segmented in Oncology, CNS Disorder, Cardiovascular Disease, Metabolic Disease, Infectious Disease, Diabetes, and Others. Based on End-User the global Healthcare CRO market is segmented in pharmaceutical companies, Medical Device Companies, and Academic Institutes.
The global Healthcare CRO market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Healthcare CRO market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Axcent Advanced Analytics (A3), BIO Agile Therapeutics, Charles River Laboratories, Covance, Inc., Firma Clinical Research, GVK Biosciences Private Limited, ICON, plc., IQVIA, Medidata Solutions, Inc., Medpace Holdings, and others are among the major players in the global Healthcare CRO market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Healthcare CRO Market has been segmented as below:
Healthcare CRO Market, By Service Type
Healthcare CRO Market, By Therapeutic Area
Healthcare CRO Market, By End-User
Healthcare CRO Market, By Region
Healthcare CRO Market, By Company
The report covers:
Report Scope:
The global Healthcare CRO market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Healthcare CRO market share. Major industry players with significant revenue share include Axcent Advanced Analytics (A3), BIO Agile Therapeutics, Charles River Laboratories, Covance, Inc., Firma Clinical Research, GVK Biosciences Private Limited, ICON, plc., IQVIA, Medidata Solutions, Inc., Medpace Holdings, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Laboratory Glassware Washers market
Mid-Revenue Cycle Management/Clinical Documentation Improvement market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. Healthcare CRO Market, By Service Type
5.1. Key Points
5.2. Early Phase Development
5.3. Clinical Research Services
5.4. Laboratory Services
5.5. Consulting Services
6. Healthcare CRO Market, By Therapeutic Area
6.1. Key Points
6.2. Oncology
6.3. CNS Disorder
6.4. Cardiovascular Disease
6.5. Metabolic Disease
6.6. Infectious Disease
6.7. Diabetes
6.8. Others
7. Healthcare CRO Market, By End-User
7.1. Key Points
7.2. Pharmaceutical companies
7.3. Medical Device Companies
7.4. Academic Institutes
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profiles
9.1 Axcent Advanced Analytics (A3)
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 BIO Agile Therapeutics
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Charles River Laboratories
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Covance, Inc.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Firma Clinical Research
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 GVK Biosciences Private Limited
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 ICON, plc.
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 IQVIA
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Medidata Solutions, Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Medpace Holdings
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Healthcare CRO Market has been segmented as below:
Healthcare CRO Market, By Service Type
Healthcare CRO Market, By Therapeutic Area
Healthcare CRO Market, By End-User
Healthcare CRO Market, By Region
Healthcare CRO Market, By Company
